Naturally Splendid Attends International Trade Shows and Presents in Geneva at NutraIngredients Awards Biotech Investing
Gradalis, Inc. Announces Initiation of a Phase 2 Study using Gradalis’ Vigil® Immunotherapy in Combination with Anti-PD-1 Technology to Treat Patients with Advanced Non-Small Cell Lung Cancer Biotech Investing
U.S. FDA Approves Rockwell’s Triferic® Powder Packet for Treating Anemia in Hemodialysis Patients Biotech Investing
Minerva Neurosciences to Report First Quarter 2016 Financial Results and Business Updates on May 3, 2016 Biotech Investing
MediWound’s NexoBrid to be Available in Japan through Kaken Pharmaceuticals Co., Ltd. Biotech Investing
AM-Pharma receives FDA fast track designation for recAP in Acute Kidney Injury, and reports completion of first stage in Phase II trial Biotech Investing
PharmaCyte Biotech’s Live-Cell Encapsulation Facility is Commissioned for GMP Manufacture Biotech Investing
Intrommune Therapeutics Announces Positive Results of Proof-of-Concept study of Oral Mucosal Immunotherapy (OMIT) Platform for the Treatment of Allergies Biotech Investing
Genetic Testing Solution for Companion Animals myPETGENE™ Launched Simultaneously Worldwide by Macrogen Biotech Investing
Allovate Therapeutics Announces Positive Results of Proof-of-Concept Study of Oral Mucosal Immunotherapy (OMIT) Biotech Investing
Vifor Fresenius Medical Care Renal Pharma and Relypsa Announce Submission of Marketing Authorization Application Requesting European Approval of Veltassa® for the Treatment of Hyperkalemia Biotech Investing
Phase II Cervical Cancer Study with Advaxis’ Axalimogene Filolisbac Selected for Poster Discussion Session at the 2016 ASCO Annual Meeting Biotech Investing
